Can flow cytometry play a part in cell based high-content screening?

Cytometry Part A

Volumn 71, Issue 11, 2007, Pages 901-904

  Muller, Christian D ^a,b   Peluso, Jean ^b   Tabaka Moreira, Helena ^b   Taquet, Nathalie ^b   Dumont, Serge ^b   Reimund, Jean Marie ^c  

^a Faculty of Pharmacy   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RESEARCH; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; IMAGING SYSTEM; LETTER; PRIORITY JOURNAL;

DRUG DESIGN; FLOW CYTOMETRY; HUMANS;

EID: 35948930247     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20455     Document Type: Letter

References (17)

1. Van Osta P, Ver Donck K, Bols L, Geysen J. Cytomics and drug discovery. Cytometry A 2006;69A:117-118.
2. Smith PJ, Khan IA, Errington RJ. Cytomics and drug development. Cytometry A 2007;71A:349-351.
3. Valet G. Cytomics: An entry to biomedical cell systems biology. Cytometry A 2005;63A:67-68.
4. Valet G. Cytomics as a new potential for drug discovery. Drug Discov Today 2006;11:785-791.
5. Lovborg H, Gullbo J, Larsson R. Screening for apoptosis - classical and emerging techniques. Anticancer Drugs 2005;16:593-599.
6. Lang P, Yeow K, Nichols A, Scheer A. Cellular imaging in drug discovery. Nat Rev Drug Discov 2006;5:343-356.
7. Edwards BS, Oprea T, Prossnitz ER, Sklar LA. Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol 2004;8:392-398.
8. Gasparetto M, Gentry T, Sebti S, O'Bryan E, Nimmanapalli R, Blaskovich MA, Bhalla K, Rizzieri D, Haaland P, Dunne J, Smith C. Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening. J Immunol Methods 2004;292:59-71.
9. Burchiel SW, Lauer FT, Gurule D, Mounho BJ, Salas VM. Uses and future applications of flow cytometry in immunotoxicity testing. Methods 1999;19:28-35.
10. Perez OD, Krutzik PO, Nolan GP. Flow cytometric analysis of kinase signaling cascades. Methods Mol Biol 2004;263:67-94.
11. Edwards BS, Kuckuck F, Sklar LA. Plug flow cytometry: An automated coupling device for rapid sequential flow cytometric sample analysis. Cytometry 1999;37:156-159.
12. Edwards BS, Kuckuck FW, Prossnitz ER, Ransom JT, Sklar LA. HTPS flow cytometry: A novel platform for automated high throughput drug discovery and characterization. J Biomol Screen 2001;6:83-90.
13. Young SM, Bologa C, Prossnitz ER, Oprea TI, Sklar LA, Edwards BS. High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands. J Biomol Screen 2005;10:374-382.
14. Edwards BS, Young SM, Oprea TI, Bologa CG, Prossnitz ER, Sklar LA. Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform. Nat Protoc 2006;1:59-66.
15. Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, et al. Workshop on cancer biometrics: Identifying biomarkers and surrogates of cancer in patients: A meeting held at the Masur Auditorium, National Institutes of Health. J Immunother 2005;28:79-119.
16. Goix P. Founder, Guava Technologies. http://www.bioe2e.org/2004/may5. html, 1997.
17. Pinna G, Reimund JM, Muller CD. [How to test at once six cytokines in samples as small as 25 microl?]. Ann Biol Clin (Paris) 2004;62:59-63.